Tarek Sahmoud
No más puestos en curso
Perfil
Tarek Sahmoud served as the Chief Medical Officer at Humanigen, Inc., Vice President at Novartis Corp., Chief Medical Officer at H3 Biomedicine, Inc., and Chief Medical Officer at Context Therapeutics, Inc. He obtained his undergraduate degree from KasrAlAiny School of Medicine in 1985 and his doctorate degree from Bordeaux Segalen University in 1995.
Antiguos cargos conocidos de Tarek Sahmoud.
Empresas | Cargo | Fin |
---|---|---|
CONTEXT THERAPEUTICS INC. | Director Técnico/Científico/I+D | 31/12/2023 |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Director Técnico/Científico/I+D | 01/07/2017 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
HUMANIGEN, INC. | Director Técnico/Científico/I+D | - |
Formación de Tarek Sahmoud.
KasrAlAiny School of Medicine | Undergraduate Degree |
Bordeaux Segalen University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
HUMANIGEN, INC. | Health Technology |
CONTEXT THERAPEUTICS INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Bolsa de valores
- Insiders
- Tarek Sahmoud